Lean patients with NAFLD are more likely to have cardiovascular disease than those with NAFLD who are overweight or living with obesity.
Continue learning about the liver during 2022 at DDW.
With the increased availability of safe and effective treatments for patients with hepatitis C (HCV), Brian L. Pearlman, MD, FACP, FAASLD, AAHIVS, identified five HCV patient populations clinicians should understand how to treat.
Nancy Reau, MD, explored COVID-19-related liver disease in severe and long-term COVID-19 infections.
New data presented by Andy Tien, MD, MS, of Kaiser Permanente Medical Center in Los Angeles points to an increased risk of dying from COVID-19 in liver transplant patients.
Barbara Andrews, NP, of the University of California San Diego Health System, illustrated the crucial steps to ensuring correct diagnosis of liver lesions and the challenges in doing so.
SSAT President Mark P. Callery, MD, highlighted presentations that reflect the wide range of recent clinical innovations and successful outcomes of surgery for the GI tract, liver and pancreas.
Researchers saw a significant increase in the number of alcohol-related gastrointestinal and liver disease consults during the COVID-19 pandemic.
During his state-of-the-art lecture, Dr. Roberts will review the emerging local and systemic therapies for HCC and describe the key changes needed to cement progress in the field.
Join Dr. Garcia-Tsao’s state-of-the-art lecture on complications of cirrhosis and strategies for reducing portal pressure on May 21.
